|
AU2003276919B2
(en)
|
2002-09-25 |
2013-05-16 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
|
|
FR2845382A1
(fr)
|
2002-10-02 |
2004-04-09 |
Sanofi Synthelabo |
Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique
|
|
EP1616862A4
(en)
*
|
2003-04-18 |
2008-07-16 |
Ono Pharmaceutical Co |
HETEROCYCLIC NITROGEN COMPOUND AND USE THEREOF
|
|
NZ544756A
(en)
|
2003-07-22 |
2009-09-25 |
Astex Therapeutics Ltd |
3,4-Disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
|
|
AR045238A1
(es)
|
2003-08-08 |
2005-10-19 |
Vertex Pharma |
Compuestos utiles como inhibidores de canales ionicos regulados por voltaje
|
|
WO2005014554A1
(en)
*
|
2003-08-08 |
2005-02-17 |
Astex Therapeutics Limited |
1h-indazole-3-carboxamide compounds as mapkap kinase modulators
|
|
WO2005063767A2
(en)
|
2003-12-22 |
2005-07-14 |
Memory Pharmaceuticals Corporation |
Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
|
|
FR2867778B1
(fr)
*
|
2004-03-16 |
2006-06-09 |
Sanofi Synthelabo |
Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme
|
|
US20050234095A1
(en)
|
2004-03-25 |
2005-10-20 |
Wenge Xie |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
|
|
JP2007534692A
(ja)
|
2004-04-22 |
2007-11-29 |
メモリー・ファーマシューティカルズ・コーポレイション |
インドール、１ｈ−インダゾール、１，２−ベンズイソキサゾール、１，２−ベンゾイソチアゾール、ならびにその調製および使用
|
|
US7632831B2
(en)
|
2004-05-07 |
2009-12-15 |
Memory Pharmaceuticals Corporation |
1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
|
|
MX2007004551A
(es)
|
2004-10-18 |
2007-05-23 |
Amgen Inc |
Compuestos tiadiazol y metodos de uso.
|
|
RU2418797C2
(ru)
|
2004-12-22 |
2011-05-20 |
Мемори Фармасьютиклз Корпорейшн |
Лиганды никотинового рецептора альфа-7, их получение и применение
|
|
AR052559A1
(es)
*
|
2005-01-21 |
2007-03-21 |
Astex Therapeutics Ltd |
Derivados de pirazol para inhibir cdk's y gsk's
|
|
AR054425A1
(es)
|
2005-01-21 |
2007-06-27 |
Astex Therapeutics Ltd |
Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
ES2349476T3
(es)
|
2005-09-09 |
2011-01-03 |
Schering Corporation |
Nuevos derivados de 4-ciano, 4-amino y 4-aminometilo de compuestos de pirazolo[1,5-a]piridinas, pirazolo[1,5-c]pirimidinas y 2h-indazol y derivados de 5-ciano, 5-amino y 5-aminometilo de compuestos de imidazo[1,2-a]piridinas e imidazo[1,5-a]pirazinas, como inhibidores de cinasa dependiente de ciclina.
|
|
US8008481B2
(en)
*
|
2006-03-31 |
2011-08-30 |
Ericsson Anna M |
Indazole compounds
|
|
US20090142337A1
(en)
*
|
2006-05-08 |
2009-06-04 |
Astex Therapeutics Limited |
Pharmaceutical Combinations of Diazole Derivatives for Cancer Treatment
|
|
AU2008276521B2
(en)
|
2007-07-17 |
2011-11-03 |
Amgen Inc. |
Heterocyclic modulators of PKB
|
|
AU2008276512A1
(en)
|
2007-07-17 |
2009-01-22 |
Amgen Inc. |
Thiadiazole modulators of PKB
|
|
WO2009106980A2
(en)
*
|
2008-02-29 |
2009-09-03 |
Pfizer Inc. |
Indazole derivatives
|
|
WO2011019648A1
(en)
*
|
2009-08-10 |
2011-02-17 |
Epitherix, Llc |
Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof
|
|
ES2835553T3
(es)
|
2009-08-10 |
2021-06-22 |
Biosplice Therapeutics Inc |
Inhibidores de indazol de la vía de señalización de Wnt y sus usos terapéuticos
|
|
WO2011031628A1
(en)
*
|
2009-09-14 |
2011-03-17 |
Schering Corporation |
Inhibitors of diacylglycerol acyltransferase
|
|
CN102821607B
(zh)
*
|
2009-12-21 |
2014-12-17 |
萨穆梅德有限公司 |
1H-吡唑并[3，4-b]吡啶及其治疗应用
|
|
WO2011143430A1
(en)
|
2010-05-12 |
2011-11-17 |
Abbott Laboratories |
Indazole inhibitors of kinase
|
|
EP3323820B1
(en)
|
2011-02-28 |
2023-05-10 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
HRP20190281T1
(hr)
|
2011-09-14 |
2019-05-31 |
Samumed, Llc |
Indazol-3-karboksamidi i njihova uporaba kao inhibitora signalizacijskog puta wnt/b-katenin
|
|
JP2015506360A
(ja)
|
2012-01-06 |
2015-03-02 |
ユニバーシティ・オブ・サウス・フロリダ |
組成物、使用方法および処置方法
|
|
US9611249B2
(en)
|
2012-02-12 |
2017-04-04 |
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. |
1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
|
|
SG10201701171TA
(en)
|
2012-02-21 |
2017-04-27 |
Acraf |
Use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
|
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
|
PL2770994T3
(pl)
|
2012-05-04 |
2020-03-31 |
Samumed, Llc |
1H-Pirazolo[3,4-b]pirydyny i ich zastosowania terapeutyczne
|
|
PE20151280A1
(es)
*
|
2012-12-21 |
2015-09-12 |
Plexxikon Inc |
Compuestos y metodos para la modulacion de quinasas y sus indicaciones
|
|
EP2943198B1
(en)
|
2013-01-08 |
2019-07-17 |
Samumed, LLC |
3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof
|
|
MA39763A
(fr)
|
2014-03-20 |
2017-01-25 |
Samumed Llc |
Indazole-3-carboxamides 5-substitués, et préparation et utilisation de ceux-ci
|
|
WO2015200650A1
(en)
*
|
2014-06-25 |
2015-12-30 |
Epizyme, Inc. |
Substituted benzene and 6,5-fused bicyclic heteroaryl compounds
|
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040188A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040182A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof
|
|
GB201511382D0
(en)
|
2015-06-29 |
2015-08-12 |
Imp Innovations Ltd |
Novel compounds and their use in therapy
|
|
WO2017024015A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017023975A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
WO2017023993A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017023987A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
WO2017024010A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
US10188634B2
(en)
|
2015-08-03 |
2019-01-29 |
Samumed, Llc |
3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10206909B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10285983B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-B] pyridines and therapeutic uses thereof
|
|
WO2017023986A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
US10231956B2
(en)
|
2015-08-03 |
2019-03-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10350199B2
(en)
|
2015-08-03 |
2019-07-16 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
US10285982B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
WO2017023972A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017023984A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
US10166218B2
(en)
|
2015-08-03 |
2019-01-01 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
US10392383B2
(en)
|
2015-08-03 |
2019-08-27 |
Samumed, Llc |
3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10519169B2
(en)
|
2015-08-03 |
2019-12-31 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
KR20180080262A
(ko)
|
2015-11-06 |
2018-07-11 |
사뮤메드, 엘엘씨 |
골관절염의 치료
|
|
MX2018006250A
(es)
|
2015-11-18 |
2018-09-05 |
Genzyme Corp |
Biomarcador de enfermedad poliquistica renal y usos del mismo.
|
|
AR108325A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
|
ES2933109T3
(es)
|
2016-06-01 |
2023-02-02 |
Biosplice Therapeutics Inc |
Proceso para preparar N-(5-(3-(7-(3-fluorofenil)-3h-imidazo[4,5-c]piridin-2-il)-1h-indazol-5-il)piridin-3-il)-3-metilbutanamida
|
|
CN110709082A
(zh)
|
2016-10-21 |
2020-01-17 |
萨穆梅德有限公司 |
吲唑-3-甲酰胺的使用方法及其作为Wnt/β-连环蛋白信号传导途径抑制剂的用途
|
|
KR102558716B1
(ko)
|
2016-11-07 |
2023-07-21 |
사뮤메드, 엘엘씨 |
단일-투여량, 즉시-사용가능한 주사용 제제
|
|
WO2018094362A1
(en)
|
2016-11-21 |
2018-05-24 |
Translational Drug Development, Llc |
Heterocyclic compounds as kinase inhibitors
|
|
ES2950451T3
(es)
*
|
2017-03-28 |
2023-10-10 |
Basf Se |
Compuestos plaguicidas
|
|
WO2019165192A1
(en)
|
2018-02-23 |
2019-08-29 |
Samumed, Llc |
5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof
|
|
UA128089C2
(uk)
|
2018-05-07 |
2024-04-03 |
Ацьєнде Кіміке Ріуніте Анджеліні Франческо - А.Чі.Р.А.Ф. С.П.А. |
1h-індазол-3-карбоксамідні сполуки як інгібітори кінази-3 бета глікогенсинтази
|
|
CA3176237A1
(en)
|
2020-04-29 |
2021-11-04 |
Jack Lin |
Synthesis of heterocyclic compounds
|
|
CN112778203B
(zh)
*
|
2021-01-29 |
2022-02-15 |
兰州交通大学 |
1h-吲唑-3-羧酸衍生物及格拉斯琼和氯尼达明的制备方法
|
|
CN114605329B
(zh)
*
|
2022-03-28 |
2024-01-26 |
河南中医药大学 |
取代的吲唑甲酰胺或取代的氮杂吲唑甲酰胺类flt3抑制剂及其用途
|
|
WO2024109642A1
(zh)
*
|
2023-07-28 |
2024-05-30 |
常州大学 |
一种苯并氮杂环类化合物作为β2-肾上腺素受体别构调节剂的应用
|